Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Z944
2. Z944 Compound
1. 1199236-64-0
2. Z944
3. Ulixacaltamide
4. Ulixacaltamide [inn]
5. Z 944
6. Qt2pjh89c3
7. N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide
8. Chembl3934636
9. Z-944
10. 1-piperidineacetamide, 4-(((3-chloro-5-fluorobenzoyl)amino)methyl)-n-(1,1-dimethylethyl)-
11. 4-(((3-chloro-5-fluorobenzoyl)amino)methyl)-n-(1,1-dimethylethyl)-1-piperidineacetamide
12. 4-[[(3-chloro-5-fluorobenzoyl)amino)methyl]-n-(1,1-dimethylethyl)-1-piperidineacetamide
13. N-({1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl}methyl)-3-chloro-5-fluorobenzamide
14. Unii-qt2pjh89c3
15. Gtpl7718
16. Schembl4271563
17. Dtxsid60659275
18. Bdbm50192689
19. Zinc68151606
20. Hy-120546
21. Cs-0078307
22. Ft-0664015
23. Q27089278
24. Dzr
| Molecular Weight | 383.9 g/mol |
|---|---|
| Molecular Formula | C19H27ClFN3O2 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 61.4 |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 490 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
81
PharmaCompass offers a list of Ulixacaltamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ulixacaltamide manufacturer or Ulixacaltamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ulixacaltamide manufacturer or Ulixacaltamide supplier.
PharmaCompass also assists you with knowing the Ulixacaltamide API Price utilized in the formulation of products. Ulixacaltamide API Price is not always fixed or binding as the Ulixacaltamide Price is obtained through a variety of data sources. The Ulixacaltamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ulixacaltamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ulixacaltamide, including repackagers and relabelers. The FDA regulates Ulixacaltamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ulixacaltamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ulixacaltamide supplier is an individual or a company that provides Ulixacaltamide active pharmaceutical ingredient (API) or Ulixacaltamide finished formulations upon request. The Ulixacaltamide suppliers may include Ulixacaltamide API manufacturers, exporters, distributors and traders.
Ulixacaltamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ulixacaltamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ulixacaltamide GMP manufacturer or Ulixacaltamide GMP API supplier for your needs.
A Ulixacaltamide CoA (Certificate of Analysis) is a formal document that attests to Ulixacaltamide's compliance with Ulixacaltamide specifications and serves as a tool for batch-level quality control.
Ulixacaltamide CoA mostly includes findings from lab analyses of a specific batch. For each Ulixacaltamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ulixacaltamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ulixacaltamide EP), Ulixacaltamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ulixacaltamide USP).
